Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas.

Mathews TP, Hill S, Rose KL, Ivanova PT, Lindsley CW, Brown HA
ACS Chem Biol. 2015 10 (5): 1258-68

PMID: 25646564 · PMCID: PMC4433586 · DOI:10.1021/cb500772c

Cancer cells reorganize their metabolic pathways to fuel demanding rates of proliferation. Oftentimes, these metabolic phenotypes lie downstream of prominent oncogenes. The lipid signaling molecule phosphatidic acid (PtdOH), which is produced by the hydrolytic enzyme phospholipase D (PLD), has been identified as a critical regulatory molecule for oncogenic signaling in many cancers. In an effort to identify novel regulatory mechanisms for PtdOH, we screened various cancer cell lines, assessing whether treatment of cancer models with PLD inhibitors altered production of intracellular metabolites. Preliminary findings lead us to focus on how deoxyribonucleoside triphosphates (dNTPs) are altered upon PLD inhibitor treatment in gliomas. Using a combination of proteomics and small molecule intracellular metabolomics, we show herein that PtdOH acutely regulates the production of these pyrimidine metabolites through activation of CAD via mTOR signaling pathways independently of Akt. These changes are responsible for decreases in dNTP production after PLD inhibitor treatment. Our data identify a novel regulatory role for PLD activity in specific cancer types.

MeSH Terms (12)

Amino Acid Sequence Brain Neoplasms Cell Line, Tumor Enzyme Inhibitors Glioma Humans Molecular Sequence Data Phospholipase D Pyrimidines Signal Transduction Structure-Activity Relationship TOR Serine-Threonine Kinases

Connections (1)

This publication is referenced by other Labnodes entities: